![]() |
市場調査レポート
商品コード
1722809
空カプセルの市場規模、シェア、動向、予測:タイプ、原材料、機能性、治療用途、エンドユーザー、地域別、2025年~2033年Empty Capsules Market Size, Share, Trends and Forecast by Type, Raw Material, Functionality, Therapeutic Application, End User, and Region, 2025-2033 |
||||||
カスタマイズ可能
|
空カプセルの市場規模、シェア、動向、予測:タイプ、原材料、機能性、治療用途、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 150 Pages
納期: 2~3営業日
|
空カプセルの世界市場規模は、2024年に32億6,000万米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに56億7,000万米ドルに達し、2025年から2033年にかけて6.28%のCAGRを示すと予測しています。現在、北米が市場を独占しており、2024年には34.5%以上の市場シェアを占めています。患者の胃腸の安全性を確保するためのカプセル・イン・カプセル技術の新たな人気が、ヘルスケア産業における数々の進歩と相まって、主にこの地域の市場を後押ししています。
主な市場促進要因:慢性疾患の有病率の増加が主に世界市場を牽引しています。さらに、ヒドロキシプロピルメチルセルロース(HPMC)のような、透明性、適度な強度、耐油性、耐脂性などによる非ゼラチンカプセルの採用が増加していることも、もう一つの重要な成長促進要因として作用しています。
主要市場動向:革新的な治療薬や医薬品を導入するためのヘルスケア分野の主要企業による広範な投資は、市場を強化する新たな動向の一つです。さらに、即時放出カプセルの開発も市場成長にプラスの影響を与えています。
地理的動向:北米は、栄養補助食品に対する健康志向の高まりにより、市場で明確な優位性を示しています。このほか、空カプセルのサプライヤーとゼラチンメーカー間のさまざまな戦略的提携が、この地域の市場の成長に寄与しています。
課題と機会:空カプセルの市場における主要課題の1つは、カプセルの安定性と幅広い医薬品有効成分(API)との適合性を確保することです。しかし、安定性を高め、多様なAPIとの相互作用を低減する革新的なカプセル材料や製剤を開発するための材料科学の継続的な改善が、今後数年間の市場の活性化につながると予想されます。
慢性疾患の発生
関連する慢性疾患を発症しやすい高齢者人口の拡大により、他の経口剤形に比べて飲み込みやすく溶解時間が早いカプセル剤による治療効果の高い医薬品の生産需要が高まっています。世界保健機関(WHO)によると、80歳以上の高齢者の数は2020年から2050年の間に3倍になり、およそ4億2,600万人に達すると予想されています。これに加えて、人口問題研究所のPopulation Bulletin-Aging in the United Statesによると、65歳以上の米国人は2018年の5,200万人から2060年には9,500万人へとほぼ倍増すると予想されています。さらに、心血管疾患(CVD)は世界的に非常に流行しています。世界保健機関(WHO)が2019年に発表したデータによると、心血管疾患の罹患率の上昇により毎年推定1,790万人が死亡しており、その数は2030年までに約2,360万人以上に増加すると予測されています。さらに、英国心臓財団センターによると、2021年には英国全土で約760万人が心臓・循環器疾患とともに暮らしています。その結果、このような症例の増加が、効果的な治療のための心血管治療薬の採用を後押ししており、空カプセルの市場の見通しを明るいものにしています。
新規製品の上市
製薬業界における高度なカプセル化ソリューションの導入が市場を活性化しています。主な企業は、ハードゼラチンカプセルのベジタリアン用代替品として機能し、特定の食生活や文化的ニーズを満たすHPMCカプセルなどの改良型空カプセルを開発しています。例えば、ハードゼラチンカプセル製造において20年以上の経験を持つ著名な空カプセルのメーカーの一つであるCapsugel社は、吸入および経口医薬用途のヒドロキシプロピルメチルセルロース(HPMC)カプセルを提供しています。もう一つの例は、2022年3月にACGが開発したACGcaps NToneで、食用由来の天然色オプションを提供し、健康志向の人々にアピールしています。さらに、受託HPMCおよびハードゼラチンカプセル製造サービスの主要企業の1つであるSuheung Capsuleは、製薬業界向けに安定性の高いハードゼラチンカプセル殻材料を提供しています。これとは別に、欧州医薬品庁(EMA)や米国食品医薬品局(FDA)による規制承認の増加により、新しい製剤のプロセスが簡素化されつつあり、これが空カプセルの市場の最近のチャンスの一つとなっています。例えば、2020年4月、ハードカプセルおよび医薬品関連機器メーカーの1つであるQualicaps社は、中東・アフリカ地域で事業を展開する多くの主要企業と代理店契約および販売パートナーシップ契約を締結し、中東・アフリカ地域でのプレゼンスを拡大しました。同様に、2020年8月、ドクター・レディ・ラボラトリーズは、シスチン尿症やウィルソン病の治療に使用できるペニシラミンのジェネリックカプセルの開発についてUSFDAの承認を取得しました。
栄養補助食品の採用
コスモポッドカプセルやタラ肝油カプセルのような、カプセルの形が好まれる化粧品や栄養補助食品の人気の高まりは、重要な成長促進要因として作用しています。IMARCが発行した報告書によると、世界の栄養補助食品市場規模は2023年に4,685億米ドルに達しました。今後、IMARCグループは、同市場が2032年までに8,563億米ドルに達し、2024年から2032年の間に6.7%の成長率(CAGR)を示すと予測しています。その結果、新しい製剤の有利な機会を可能にするカプセル状のサプリメントの導入が、空カプセルの市場の需要を促進しています。例えば、2023年12月、ムンバイを拠点とするカプセル製造業者の1つであるACG社は、カプセルを2つのコンパートメントに分離するサイド・バイ・サイド技術を使用することにより、液体と粉末のような2つの異なる形態の成分を1つのカプセルにすることを可能にする栄養補助食品の斬新なデザインを開発しました。これとは別に、栄養補助食品ラベルデータベース(DSLD)のデータから、およそ5万種類の栄養補助食品カプセル、ソフトジェル、錠剤、粉末、液体、グミ、分包製品があることが明らかになりました。これらの製品のほとんどは、単一のビタミン、マルチビタミン、アミノ酸、ハーブ、マルチミネラルなどの多数の剤形です。さらに、DSLDのデータによると、17,000以上の製品がいくつかのカテゴリーでカプセルとして販売されており、全用量形態の中で34%のシェアを占めています。これが世界市場を牽引しています。
The global empty capsules market size was valued at USD 3.26 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.67 Billion by 2033, exhibiting a CAGR of 6.28% from 2025-2033. North America currently dominates the market, holding a market share of over 34.5% in 2024. The emerging popularity of capsule-in-capsule technology to ensure the gastrointestinal safety of patients, coupled with numerous advancements in the healthcare industry is primarily fueling the market in this region.
Major Market Drivers: The increasing prevalence of chronic diseases is primarily driving the global market. Moreover, the rising adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC), due to its transparency, moderate strength, resistance to oil and fat properties, etc., is also acting as another significant growth-inducing factor.
Key Market Trends: The widespread investments by key players in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs are among the emerging trends bolstering the market. Furthermore, the development of immediate-release capsules is also positively influencing the market growth.
Competitive Landscape: Some of the prominent companies in the global market include ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd, and Sunil Healthcare Limited, among many others.
Geographical Trends: North America exhibits a clear dominance in the market, owing to the increasing inclination among health-conscious individuals towards dietary supplements. Besides this, various strategic collaborations between empty capsule suppliers and gelatin manufacturers are contributing to the growth of the regional market.
Challenges and Opportunities: One of the major challenges in the empty capsules market is ensuring the stability and compatibility of capsules with a wide range of active pharmaceutical ingredients (APIs). However, continuous improvements in material science to develop innovative capsule materials and formulations that enhance stability and reduce interactions with diverse APIs are expected to fuel the market in the coming years.
Occurrence of Chronic Diseases
The expanding geriatric population who are susceptible to developing associated chronic conditions is escalating the demand for the production of therapeutically effective medicines in the form of capsules, as they are easy to swallow and have faster dissolution times compared to other oral dosage forms. According to the World Health Organization (WHO), the number of individuals aged 80 years or older is anticipated to triple between 2020 and 2050, reaching roughly about 426 million. Besides this, as stated by the Population Reference Bureau's Population Bulletin-Aging in the United States, the Americans aged 65 years and older are expected to nearly double from 52 million in 2018 to 95 million by 2060. Additionally, cardiovascular diseases (CVDs) are highly prevalent globally. As per the data published by the World Health Organization in 2019, an estimated 17.9 million people die each year due to the elevating incidences of cardiovascular diseases, and the number is projected to grow approximately to more than 23.6 million by 2030. Moreover, according to the British Heart Foundation Centre, around 7.6 million individuals were living with heart and circulatory diseases in 2021 across the United Kingdom. As a result, the rising incidences of these cases are bolstering the adoption of cardiovascular therapy drugs for effective treatment, which is providing a positive empty capsules market outlook.
Novel Product Launches
The introduction of advanced encapsulation solutions in the pharmaceutical industry is fueling the market. Key players are developing enhanced empty capsule variants, such as HPMC capsules, that serve as vegetarian alternatives to hard gelatin capsules and satisfy certain dietary and cultural needs. For example, Capsugel, one of the prominent empty capsules manufacturers with more than 20 years of experience in hard gelatin capsule manufacturing, amongst other technologies, provides a range of hydroxy propyl methyl cellulose (HPMC) capsules for inhalation and oral pharmaceutical applications. Another instance is the development of ACGcaps NTone by ACG in March 2022, which offers natural color options derived from edible sources, appealing to health-conscious individuals. Moreover, Suheung Capsule, one of the key players in contract HPMC and hard gelatin capsule manufacturing services, offers highly stable hard gelatin capsule shell materials for the pharmaceutical industry. Apart from this, the increasing number of regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) are simplifying the process of new formulations, which, in turn, is one of the empty capsules market recent opportunities. For example, in April 2020, Qualicaps, one of the manufacturers of hard capsules and pharmaceutical-related equipment, expanded its presence in the Middle East and Africa after signing agency and distribution partnership agreements with a number of leading companies operating in the region. Similarly, in August 2020, Dr. Reddy Laboratories received USFDA approval for the development of generic Penicillamine capsules that can be used for the treatment of cystinuria and Wilson's disease.
Adoption of Dietary Supplements
The inflating popularity of cosmeceuticals and nutraceuticals that are preferred in capsule forms, such as CosmoPod capsules and cod liver oil capsules, respectively, is acting as a significant growth-inducing factor. According to the report published by IMARC, the global nutraceuticals market size reached US$ 468.5 Billion in 2023. Looking forward, IMARC Group anticipated the market to reach US$ 856.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Consequently, the introduction of supplements in the form of capsules that allow lucrative opportunities for new formulations is propelling the empty capsules market demand. For instance, in December 2023, ACG, one of the Mumbai-based capsule manufacturing providers, developed a novel design for nutraceuticals by using side by sides technology that separates capsules into two compartments, thereby enabling ingredients of two different forms, such as liquid and powder, to be made into one capsule. Apart from this, the data from the Dietary Supplements Label Database (DSLD) revealed that roughly 50,000 dietary supplement capsules, softgel, tablet, powder, liquid, gummy, and packet products are available. Most of these products are numerous dosage forms of single vitamins, multi-vitamins, amino acids, herbals, multi-minerals, etc. Moreover, the DSLD data stated that more than 17,000 products are available as capsules under several categories, accounting for a 34 % share among all dosage forms. This, in turn, is driving the global market.
Currently, gelatin capsule accounts for the largest market share
Gelatin capsules, also called gel caps, represent a popular form of oral dosage used in the nutraceutical and pharmaceutical industries due to their ease of use, versatility, and ability to mask unpleasant tastes and odors of enclosed substances. Moreover, they are commonly available in both hard and soft forms. Hard gelatin capsules are widely used for dry, powdered ingredients and pellets, while soft gelatin capsules are ideal for oils and liquid-based formulations. The introduction of gelatin capsules with optimal properties, such as improved stability and modified release profiles, is augmenting the segment's growth. For instance, companies, such as Suheung, offer EMBO CAPS capsules that are manufactured to optimize stability. These capsules are also produced by adopting high-grade raw materials, including gelatine, which is sourced from Geltech, a subsidiary of Suheung. In addition, stringent specification compliance and computerized raw material cross-blending ensure only powders that meet the exact requirements can reach the capsulation machines. Apart from this, in February 2023, Vivion, Inc. introduced a wide range of empty gelatin capsules.
Among these, pig meat exhibits a clear dominance in the empty capsules market share
Pig meat, specifically pork-derived gelatin, exhibits a clear dominance in the market share, owing to its widespread availability and excellent gelling properties, which are crucial for capsule manufacturing. Pork gelatin is favored for its consistent quality and ability to form strong and flexible capsules that dissolve readily in the stomach. For example, Capsugel adopts pork-derived gelatin in their widely used capsules, thereby ensuring reliable performance. Additionally, in November 2021, the International Gelatin Manufacturers Association reported that approximately 85% of the gelatin used in pharmaceutical applications, including capsules, is derived from pork. This dominance is also driven by the well-established supply chains and lower production costs associated with pork gelatin compared to other sources, such as bovine or fish gelatin. Despite the growing interest in alternative sources due to dietary restrictions and ethical concerns, pork gelatin remains the preferred choice in the industry.
Currently, immediate-release capsules account for the majority of the global market share
The inflating need for delivering medications that require rapid onset of action is augmenting the growth in this segment. Immediate-release capsules dissolve quickly in the stomach, releasing their contents promptly for fast therapeutic effects, which makes them ideal for a broad range of pharmaceutical and nutraceutical products. For example, in August 2022, ACG launched its line of immediate-release capsules, ACGcaps IR, which are specifically designed to optimize the release profile of active ingredients, enhancing their efficacy and patient compliance. Similarly, in January 2023, Capsugel introduced their Vcaps Plus capsules with immediate-release properties, tailored for high-speed filling processes and ensuring quick dissolution and bioavailability. These innovations cater to the escalating demand for effective and fast-acting medications, which is elevating the empty capsules market's recent price.
The rising usage of capsules in antibiotics like amoxicillin helps to improve patient adherence due to their ease of swallowing and controlled dosage forms. Additionally, vitamins and dietary supplements also comprise a large portion of the market, driven by the growing consumer focus on health and wellness. Capsules offer a convenient way to consume essential nutrients, such as omega-3 fatty acids and vitamin D, which are often found in capsule form. Antacid and antiflatulent preparations benefit from the ability of capsules to deliver fast-acting relief from digestive issues. In cardiovascular therapy, they ensure the accurate delivery of drugs like statins and antihypertensives, which are crucial for managing chronic heart conditions. Besides this, other therapeutic areas, including pain management and hormonal therapies, utilize capsules for their versatility and efficacy in drug delivery, which is expected to bolster the empty capsules market revenue in the coming years.
Currently, the pharmaceutical industry account for the majority of the global market share
As per the empty capsules market statistics, the escalating demand for patient-friendly delivery methods is stimulating the market. Empty capsules provide a reliable form for encapsulating various types of medications, from powders and granules to liquids and semisolids. For instance, in September 2023, Lonza reported a significant increase in demand for its Capsugel hard gelatin capsules, driven by their use in novel drug formulations and clinical trials. These capsules are favored for their consistent performance and compatibility with a wide range of active pharmaceutical ingredients (APIs). Similarly, Qualicaps developed its new line of Quali-G hard gelatin capsules, which is designed specifically for high-potency drugs, which require precise dosing and enhanced stability. Key players in the pharmaceutical industry also leverage empty capsules for controlled-release formulations, enhancing therapeutic efficacy and patient compliance.
According to the empty capsules market overview, North America currently dominates the global market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The increasing incidences of chronic diseases, along with the expanding geriatric population in the United States, are stimulating the regional market. According to the Population Reference Bureau's Population Bulletin-Aging in the United States, the number of individuals aged 65 years and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. Besides this, the escalating demand for capsule-based nutraceutical formulations is also acting as another significant growth-inducing factor. As per the CRN Consumer Survey, 77% of Americans reported consuming dietary supplements in 2019. Moreover, the survey revealed that vitamins and minerals were the most common supplements consumed by the population across the United States in the same year, accounting for 76% of total dietary supplement consumption. Apart from this, the well-structured healthcare systems in Canada are also encouraging investments in R&D activities, which are anticipated to fuel the empty capsules market in North America over the forecasted period.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major empty capsules market companies have also been provided. Some of the key players in the market include: